❌

Normal view

Received — 10 September 2026 ⏭ Oncogenesis - nature.com science feeds

Oncogenesis - nature.com science feeds
Disruption of the AR/ZNF217/PROM2 axis sensitizes prostate cancer to ferroptosis and enzalutamide therapy Wenjun Hao · Peng Liang · Wanglong Zheng · Minglu Sheng · Yulin Peng · Xiang Gao · Haolin Zhao · Yuyan Zhu · Yanlong Wang · Bo Fan · Zhihong Dai · Xu Sun · Liang Wang · Huan Qi · Ying Wang · Yan Wang · Zhenlong Yu · Zhiyu Liu
Oncogenesis, Published online: 11 August 2026; doi:10.1038/s41389-026-00649-7Disruption of the AR/ZNF217/PROM2 axis sensitizes prostate cancer to ferroptosis and enzalutamide therapy
11 August 2026 at 08:00

Disruption of the AR/ZNF217/PROM2 axis sensitizes prostate cancer to ferroptosis and enzalutamide therapy

Oncogenesis - nature.com science feeds

By: Wenjun Hao · Peng Liang · Wanglong Zheng · Minglu Sheng · Yulin Peng · Xiang Gao · Haolin Zhao · Yuyan Zhu · Yanlong Wang · Bo Fan · Zhihong Dai · Xu Sun · Liang Wang · Huan Qi · Ying Wang · Yan Wang · Zhenlong Yu · Zhiyu Liu

11 August 2026 at 08:00

Oncogenesis, Published online: 11 August 2026; doi:10.1038/s41389-026-00649-7

Disruption of the AR/ZNF217/PROM2 axis sensitizes prostate cancer to ferroptosis and enzalutamide therapy